Skip to main content

Table 3 Adjusted factors for reported consistent gel use

From: Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda

Characteristic

Age aOR (95% CI)

LRTPvalue

aOR (95% CI)

LRTPvalue

All participants

    

Age group

    

17–24

N/A

 

1

<0.01

25–34

  

2.6 (1.6–4.3)

 

≥35

  

2.2 (1.3–3.8)

 

Rooms used for sleeping in at home

    

One

1

0.03

1

0.03

Two

1.2 (0.8–1.9)

 

1.2 (0.8–1.9)

 

Three+

1.9 (1.2–3.1)

 

1.9 (1.2–3.0)

 

Trial arm

    

Placebo

1

0.58

1

0.52

PRO2000

1.1 (0.8–1.6)

 

1.1 (0.8–1.6)

 

Employment status

    

Employed

1

0.11

1

0.13

Unemployed

1.5 (0.9–2.4)

 

1.4 (0.8–2.3)

 

Pregnancy status

    

Positive

1

0.11

1

0.50

Negative

1.5 (0.9–2.5)

 

1.2 (0.7–1.9)

 
  1. Age aOR, age adjusted odds ratio; CI, confidence interval; LRT, likelihood ratio test; aOR, adjusted odds ratio: factors adjusted for age, number of rooms used for sleeping in at home, trial arm allocation, employment and pregnancy status.